CHAPTER 10. California Affordable Drug Manufacturing Act of 2020

Chapter 10 added by Stats. 2020, Ch. 207, Sec. 1.

§§ 127690–127697 · 9 sections

• § 127690 This chapter may be cited as the California Affordable Drug Manufacturing Act of 2020.
• § 127691 For purposes of this chapter, the following definitions apply: (a) “Generic drug” means a drug that is approved pursuant to subdivision (j) of Section 355 of…
• § 127692 (a) The California Health and Human Services Agency (CHHSA) or its departments shall enter into partnerships, consistent with subdivision (b) of Section…
• § 127693 (a) CHHSA shall enter into partnerships resulting in the production, procurement, or distribution of generic prescription drugs, with the intent that these…
• § 127694 (a) On or before December 31, 2023, CHHSA shall submit a report to the Legislature that assesses the feasibility of directly manufacturing generic prescription…
• § 127694.1 Upon appropriation by the Legislature, CHHSA shall develop a California-based manufacturing facility for insulin, with the intent of creating high-skill,…
• § 127695 (a) On or before December 31, 2022, CHHSA shall report to the Legislature on both of the following: (1) A description of the status of all drugs targeted under…
• § 127696 Notwithstanding any other provision of law, all nonpublic information and documents obtained or prepared under this chapter shall not be required to be…
• § 127697 In addition to partnerships authorized pursuant to Sections 127692 and 127693, the California Health and Human Services Agency may, subject to an appropriation…